Article info

Download PDFPDF

Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study

Authors

  1. Correspondence to Professor Tsutomu Takeuchi, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan; tsutake{at}z5.keio.jp
View Full Text

Citation

Takeuchi T, Genovese MC, Haraoui B, et al
Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study

Publication history

  • Received February 19, 2018
  • Revised July 25, 2018
  • Accepted August 10, 2018
  • First published September 7, 2018.
Online issue publication 
January 10, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.